425.453.0404

US FDA Approved Trials For Bipolar Depression

Bipolar Depression

GZMJ: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment with Brenipatide in Delaying Time to Relapse Compared with Placebo in Adult Participants with Bipolar Disorder (RENEW-Bipolar-1)

NCT07286175

M25-526: A Phase 2, Multicenter, 6-Week, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Icalcaprant in Subjects with Bipolar Depression

NCT06696755

LB-102-011: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients with Major Depressive Episodes Associated with Bipolar I Disorder

NCT07494305

Study Evaluation Process

  • Screening: Determine eligibility and safety through medical examinations, questionnaires, and interviews.
  • Informed Consent: Receive detailed information about the trial, including risks and benefits.
  • Treatment: Receive investigational medication and placebo, and follow the trail protocol regarding current treatments and medications.
  • Monitoring: Close monitoring of conditions and side effects through check-ups, laboratory tests, EKG’s and assessments.

NWCRC in Bellevue, WA. Research and medical studies patient lounge.

CONTACT US

To be contacted about this study, fill out the contact form or call 425-453-0404.

This field is for validation purposes and should be left unchanged.
We complete all visits in person. Do you live within 50 miles of Bellevue, WA?(Required)


Are you interested in participating in clinical trials?(Required)


Please indicated which study you are interested in.(Required)